<?xml version="1.0" encoding="UTF-8"?><ns2:project xmlns:ns1="http://gtr.rcuk.ac.uk/gtr/api" xmlns:ns2="http://gtr.rcuk.ac.uk/gtr/api/project" xmlns:ns3="http://gtr.rcuk.ac.uk/gtr/api/fund" xmlns:ns4="http://gtr.rcuk.ac.uk/gtr/api/person" xmlns:ns5="http://gtr.rcuk.ac.uk/gtr/api/project/outcome" xmlns:ns6="http://gtr.rcuk.ac.uk/gtr/api/organisation" ns1:created="2026-07-08T08:44:08Z" ns1:href="http://gtr.ukri.org/gtr/api/projects/E82A6934-93E8-45F6-AF80-E318394A94D4" ns1:id="E82A6934-93E8-45F6-AF80-E318394A94D4"><ns1:links><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/persons/E3ED4F38-8E9B-4626-9F5D-62E8A579EB86" ns1:rel="PM_PER"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/834E59EB-695D-40D6-97A1-01A7FC462E4C" ns1:rel="LEAD_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/834E59EB-695D-40D6-97A1-01A7FC462E4C" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:end="2020-08-30T23:00:00Z" ns1:href="http://gtr.ukri.org/gtr/api/funds/091ED789-69D5-4D05-BF31-9F6388D52BED" ns1:rel="FUND" ns1:start="2018-08-31T23:00:00Z"/></ns1:links><ns2:identifiers><ns2:identifier ns2:type="RCUK">104470</ns2:identifier></ns2:identifiers><ns2:title>SENSOR FOR INCONTINENCE MANAGEMENT</ns2:title><ns2:status>Closed</ns2:status><ns2:grantCategory>Collaborative R&amp;D</ns2:grantCategory><ns2:leadFunder>Innovate UK</ns2:leadFunder><ns2:abstractText>NHS estimates, 3-6 million people in the UK have urinary incontinence of which 3 million are regularly incontinent and there are 360 incontinence clinics in the UK alone. Elsewhere, there are 240 million sufferers in the western world; 25 million in Europe requiring 15 million manual incontinence assessments per year. Associated labour costs are estimated at $20 bn; $9 bn worth of UI products are sold each year, expected to rise to $30 bn by 2030\. Considering labour and consumables, the management of incontinence is arguably the biggest single cost for long-term residential aged care facilities. The market for incontinence nappies reached USD9.2 bn globally in 2015, growing at 7.5% according to Consumer Edge Research/Euromonitor. Incontinence nappies are being routinely used for the management of UI. They often have a colour indicator to show when change is required. The colour change depends on pH acidity values, is not totally reliable. They also require regular checks causing loss of dignity and significant cost implications. Oxford Caresense Ltd. is developing a novel low cost disposable wetness sensor with major advantages: i) no electricity or chemicals involved therefore very safe ii) enable remote monitoring of all patients simultaneously ii) saving cost by enabling &amp;quot;just-in-time&amp;quot; change iii) reducing incidences of secondary problems such as nappy dermatitis and v) enable self-management.</ns2:abstractText></ns2:project>